Average Co-Inventor Count = 5.60
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (84 from 2,070 patents)
2. Astex Therapeutics Limited (9 from 122 patents)
3. Other (3 from 831,952 patents)
4. Janssen Pharmacuetica N.v. (1 from 3 patents)
97 patents:
1. 12145961 - Spirobicyclic analogues
2. 11993614 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
3. 11883367 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
4. 11702441 - Spirobicyclic analogues
5. 11318157 - 6-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitors
6. 11267804 - (R)-8-(1-((3-fluorophenyl)amino)ethyl)-N-(2-hydroxyethyl)-2-morpholinoquinoxaline-6-carboxamide for inhibiting phosphoinositide-3-kinase activity
7. 11236084 - Substituted azaindoline derivatives as NIK inhibitors
8. 11186589 - Cyanoindoline derivatives as NIK inhibitors
9. 11180487 - Substituted cyanoindoline derivatives as NIK inhibitors
10. 11136311 - Heteroaromatic derivatives as NIK inhibitors
11. 11130751 - Quinoxaline and pyridopyrazine derivatives as PI3K-beta inhibitors
12. 11098062 - Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitors
13. 11059850 - Spirobicyclic analogues
14. 11001569 - 6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors
15. 10981926 - Substituted thiohydantoin derivatives as androgen receptor antagonists